Literature DB >> 27568149

Computer-Aided Nodule Assessment and Risk Yield Risk Management of Adenocarcinoma: The Future of Imaging?

Finbar Foley1, Srinivasan Rajagopalan2, Sushravya M Raghunath2, Jennifer M Boland3, Ronald A Karwoski4, Fabien Maldonado5, Brian J Bartholmai2, Tobias Peikert6.   

Abstract

Increased clinical use of chest high-resolution computed tomography results in increased identification of lung adenocarcinomas and persistent subsolid opacities. However, these lesions range from very indolent to extremely aggressive tumors. Clinically relevant diagnostic tools to noninvasively risk stratify and guide individualized management of these lesions are lacking. Research efforts investigating semiquantitative measures to decrease interrater and intrarater variability are emerging, and in some cases steps have been taken to automate this process. However, many such methods currently are still suboptimal, require validation and are not yet clinically applicable. The computer-aided nodule assessment and risk yield software application represents a validated tool for the automated, quantitative, and noninvasive tool for risk stratification of adenocarcinoma lung nodules. Computer-aided nodule assessment and risk yield correlates well with consensus histology and postsurgical patient outcomes, and therefore may help to guide individualized patient management, for example, in identification of nodules amenable to radiological surveillance, or in need of adjunctive therapy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  lung adenocarcinoma; lung cancer screening; pulmonary nodule; quantitative image analytics; risk stratification

Mesh:

Year:  2016        PMID: 27568149      PMCID: PMC5003324          DOI: 10.1053/j.semtcvs.2015.12.015

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  28 in total

1.  Solitary pulmonary nodule: high-resolution CT and radiologic-pathologic correlation.

Authors:  C V Zwirewich; S Vedal; R R Miller; N L Müller
Journal:  Radiology       Date:  1991-05       Impact factor: 11.105

2.  Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results.

Authors:  Junji Yoshida; Genichiro Ishii; Tomoyuki Hishida; Keiju Aokage; Masahiro Tsuboi; Hiroyuki Ito; Tomoyuki Yokose; Haruhiko Nakayama; Kouzo Yamada; Kanji Nagai
Journal:  Jpn J Clin Oncol       Date:  2015-04-21       Impact factor: 3.019

3.  Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules.

Authors:  Masayuki Nakao; Junji Yoshida; Koichi Goto; Genichiro Ishii; Akikazu Kawase; Keiju Aokage; Tomoyuki Hishida; Mitsuyo Nishimura; Kanji Nagai
Journal:  J Thorac Oncol       Date:  2012-10       Impact factor: 15.609

4.  Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study.

Authors:  Fabien Maldonado; Jennifer M Boland; Sushravya Raghunath; Marie Christine Aubry; Brian J Bartholmai; Mariza Deandrade; Thomas E Hartman; Ronald A Karwoski; Srinivasan Rajagopalan; Anne-Marie Sykes; Ping Yang; Eunhee S Yi; Richard A Robb; Tobias Peikert
Journal:  J Thorac Oncol       Date:  2013-04       Impact factor: 15.609

5.  Pathologic N0 status in pulmonary adenocarcinoma is predictable by combining serum carcinoembryonic antigen level and computed tomographic findings.

Authors:  K Takamochi; K Nagai; J Yoshida; K Suzuki; Y Ohde; M Nishimura; S Sasaki; Y Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2001-08       Impact factor: 5.209

6.  Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial.

Authors:  Fabien Maldonado; Fenghai Duan; Sushravya M Raghunath; Srinivasan Rajagopalan; Ronald A Karwoski; Kavita Garg; Erin Greco; Hrudaya Nath; Richard A Robb; Brian J Bartholmai; Tobias Peikert
Journal:  Am J Respir Crit Care Med       Date:  2015-09-15       Impact factor: 21.405

7.  A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201).

Authors:  Kenji Suzuki; Teruaki Koike; Takashi Asakawa; Masahiko Kusumoto; Hisao Asamura; Kanji Nagai; Hirohito Tada; Tetsuya Mitsudomi; Masahiro Tsuboi; Taro Shibata; Haruhiko Fukuda; Harubumi Kato
Journal:  J Thorac Oncol       Date:  2011-04       Impact factor: 15.609

8.  Reproducibility and Prognosis of Quantitative Features Extracted from CT Images.

Authors:  Yoganand Balagurunathan; Yuhua Gu; Hua Wang; Virendra Kumar; Olya Grove; Sam Hawkins; Jongphil Kim; Dmitry B Goldgof; Lawrence O Hall; Robert A Gatenby; Robert J Gillies
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

9.  Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography.

Authors:  Sushravya Raghunath; Fabien Maldonado; Srinivasan Rajagopalan; Ronald A Karwoski; Zackary S DePew; Brian J Bartholmai; Tobias Peikert; Richard A Robb
Journal:  J Thorac Oncol       Date:  2014-11       Impact factor: 15.609

10.  Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.

Authors:  Zhao Li; Bo Ye; Minwei Bao; Binbin Xu; Qinyi Chen; Sida Liu; Yudong Han; Mingzhen Peng; Zhifeng Lin; Jingpei Li; Wenzhuo Zhu; Qiang Lin; Liwen Xiong
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

View more
  8 in total

1.  Appreciating the shades of gray: a case for Computer-Aided Nodule Assessment and Risk Yield (CANARY)-based risk stratification of lung adenocarcinomas.

Authors:  Fabien Maldonado; Tobias Peikert; Brian J Bartholmai; Srinivasan Rajagopalan; Ronald A Karwoski
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

2.  While size matters-advanced "Radiomics" remain promising for the clinical management of ground glass opacities.

Authors:  Tobias Peikert; Srinivasan Rajagopalan; Brian Bartholmai; Fabien Maldonado
Journal:  J Thorac Dis       Date:  2017-10       Impact factor: 2.895

3.  Added Value of Computer-aided CT Image Features for Early Lung Cancer Diagnosis with Small Pulmonary Nodules: A Matched Case-Control Study.

Authors:  Peng Huang; Seyoun Park; Rongkai Yan; Junghoon Lee; Linda C Chu; Cheng T Lin; Amira Hussien; Joshua Rathmell; Brett Thomas; Chen Chen; Russell Hales; David S Ettinger; Malcolm Brock; Ping Hu; Elliot K Fishman; Edward Gabrielson; Stephen Lam
Journal:  Radiology       Date:  2017-09-05       Impact factor: 11.105

Review 4.  Lung cancer screening: nodule identification and characterization.

Authors:  Ioannis Vlahos; Konstantinos Stefanidis; Sarah Sheard; Arjun Nair; Charles Sayer; Joanne Moser
Journal:  Transl Lung Cancer Res       Date:  2018-06

Review 5.  Putting artificial intelligence (AI) on the spot: machine learning evaluation of pulmonary nodules.

Authors:  Yasmeen K Tandon; Brian J Bartholmai; Chi Wan Koo
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

6.  How AI Can Help in the Diagnostic Dilemma of Pulmonary Nodules.

Authors:  Dalia Fahmy; Heba Kandil; Adel Khelifi; Maha Yaghi; Mohammed Ghazal; Ahmed Sharafeldeen; Ali Mahmoud; Ayman El-Baz
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

7.  Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial.

Authors:  Tobias Peikert; Fenghai Duan; Srinivasan Rajagopalan; Ronald A Karwoski; Ryan Clay; Richard A Robb; Ziling Qin; JoRean Sicks; Brian J Bartholmai; Fabien Maldonado
Journal:  PLoS One       Date:  2018-05-14       Impact factor: 3.240

8.  HLA-DR cancer cells expression correlates with T cell infiltration and is enriched in lung adenocarcinoma with indolent behavior.

Authors:  Maria-Fernanda Senosain; Yong Zou; Tatiana Novitskaya; Georgii Vasiukov; Aneri B Balar; Dianna J Rowe; Deon B Doxie; Jonathan M Lehman; Rosana Eisenberg; Fabien Maldonado; Andries Zijlstra; Sergey V Novitskiy; Jonathan M Irish; Pierre P Massion
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.